Quinolone resistance and biofilm formation capability of uropathogenic Escherichia coli isolates from an Iranian inpatients' population.
Biofilm
Qnr genes
Uropathogenic Escherichia coli
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
11
05
2023
accepted:
20
07
2023
medline:
23
10
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
Uropathogenic Escherichia coli (UPEC) is a major pathogen of the urinary tract infection (UTI), and biofilm formation is crucial as it facilitates the colonization in the urinary tract. We aimed to investigate the antibiotic susceptibility pattern, biofilm formation capability, distribution of quinolone resistance genes, and phylogenetic groups among UPEC isolates from an Iranian inpatients' community. A collection of 126 UPEC obtained from hospitalized patients with symptomatic UTI at 3 teaching hospitals during 2016 were included. Antibiogram of all isolates against quinolone and fluoroquinolones was performed using the disk diffusion method. Phylogenetic groups and qnr A, B, and S genes were assessed by PCR. Susceptibility pattern showed that more than 50% and 81% of the isolates were resistant to fluoroquinolones and quinolones, correspondingly. The frequency of qnrS and qnrB genes was 22% and 13.5%, correspondingly. Our result indicated no significant association between the presence of fluoroquinolone genes and antibiotic resistance to them. The frequent common phylogroup was B2 (84.1%), followed by D (10.3%), A (3.2%) and B1 (2.4%) groups. Indeed, 80.2% of the isolates were biofilm producers, so that 42.1%, 16.7% and 21.4% of them were classified as weak, moderate and strong producers, respectively. Our results showed considerable fluoroquinolone and quinolone resistance among UPEC along with a remarkable rate of biofilm-producing isolates from symptomatic hospitalized patients, making them a serious health concern in the region. This survey highlights the need for awareness on quinolone resistance and careful prescription of them by physicians.
Sections du résumé
BACKGROUND
BACKGROUND
Uropathogenic Escherichia coli (UPEC) is a major pathogen of the urinary tract infection (UTI), and biofilm formation is crucial as it facilitates the colonization in the urinary tract. We aimed to investigate the antibiotic susceptibility pattern, biofilm formation capability, distribution of quinolone resistance genes, and phylogenetic groups among UPEC isolates from an Iranian inpatients' community.
METHODS AND RESULTS
RESULTS
A collection of 126 UPEC obtained from hospitalized patients with symptomatic UTI at 3 teaching hospitals during 2016 were included. Antibiogram of all isolates against quinolone and fluoroquinolones was performed using the disk diffusion method. Phylogenetic groups and qnr A, B, and S genes were assessed by PCR. Susceptibility pattern showed that more than 50% and 81% of the isolates were resistant to fluoroquinolones and quinolones, correspondingly. The frequency of qnrS and qnrB genes was 22% and 13.5%, correspondingly. Our result indicated no significant association between the presence of fluoroquinolone genes and antibiotic resistance to them. The frequent common phylogroup was B2 (84.1%), followed by D (10.3%), A (3.2%) and B1 (2.4%) groups. Indeed, 80.2% of the isolates were biofilm producers, so that 42.1%, 16.7% and 21.4% of them were classified as weak, moderate and strong producers, respectively.
CONCLUSIONS
CONCLUSIONS
Our results showed considerable fluoroquinolone and quinolone resistance among UPEC along with a remarkable rate of biofilm-producing isolates from symptomatic hospitalized patients, making them a serious health concern in the region. This survey highlights the need for awareness on quinolone resistance and careful prescription of them by physicians.
Identifiants
pubmed: 37540453
doi: 10.1007/s11033-023-08704-x
pii: 10.1007/s11033-023-08704-x
doi:
Substances chimiques
Anti-Bacterial Agents
0
Quinolones
0
Fluoroquinolones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8073-8079Subventions
Organisme : Shiraz University of Medical Sciences
ID : Grant number 15584
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Int J Gen Med. 2011;4:333-43
pubmed: 21674026
J Glob Antimicrob Resist. 2020 Mar;20:197-203
pubmed: 31398493
Asian Pac J Trop Med. 2012 Mar;5(3):210-3
pubmed: 22305786
Osong Public Health Res Perspect. 2016 Oct;7(5):307-312
pubmed: 27812489
Front Microbiol. 2017 Aug 15;8:1566
pubmed: 28861072
J Urol. 2007 Jan;177(1):365-8
pubmed: 17162092
Iran J Basic Med Sci. 2018 Dec;21(12):1226-1231
pubmed: 30627365
Infect Drug Resist. 2019 Jul 17;12:2039-2047
pubmed: 31410031
Microb Pathog. 2015 Dec;89:188-94
pubmed: 26518125
Comp Immunol Microbiol Infect Dis. 2019 Aug;65:148-153
pubmed: 31300106
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:65-72
pubmed: 14527774
NPJ Biofilms Microbiomes. 2016;2:
pubmed: 28480050
Iran J Microbiol. 2022 Dec;14(6):841-849
pubmed: 36721438
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Antimicrob Resist Infect Control. 2016 Apr 01;5:11
pubmed: 27042294
Jundishapur J Microbiol. 2015 Jul 25;8(7):e19184
pubmed: 26421128
Infect Drug Resist. 2019 Jun 19;12:1683-1689
pubmed: 31354317
Microb Pathog. 2017 Sep;110:540-545
pubmed: 28760455
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
Trop Biomed. 2018 Mar 1;35(1):195-204
pubmed: 33601792
Clin Infect Dis. 2016 Oct 1;63(7):960-5
pubmed: 27313263
Biomed Res Int. 2015;2015:846219
pubmed: 25692147
Exp Mol Pathol. 2008 Aug;85(1):11-9
pubmed: 18482721
PLoS One. 2018 May 14;13(5):e0196260
pubmed: 29758033
Pathogens. 2016 Nov 30;5(4):
pubmed: 27916925
Int J Nephrol. 2012;2012:681473
pubmed: 22506110
Braz J Microbiol. 2011 Apr;42(2):462-6
pubmed: 24031655
BMC Microbiol. 2010 Jun 01;10:161
pubmed: 20515490
BMC Microbiol. 2020 Aug 5;20(1):241
pubmed: 32758126
Trop Med Infect Dis. 2022 Sep 08;7(9):
pubmed: 36136646
Can J Microbiol. 2019 Jan;65(1):34-44
pubmed: 30248271
Adv Biomed Res. 2018 Mar 27;7:40
pubmed: 29657925
Antimicrob Agents Chemother. 2009 Feb;53(2):639-45
pubmed: 19064896
Int J Mol Sci. 2017 Sep 30;18(10):
pubmed: 28973965
BMC Microbiol. 2022 Apr 6;22(1):89
pubmed: 35387587
J Infect Public Health. 2014 Sep-Oct;7(5):413-9
pubmed: 24861644
PLoS One. 2018 Jan 4;13(1):e0190729
pubmed: 29300775
Biomed Res Int. 2019 May 20;2019:5712371
pubmed: 31236408